Clinical Practice Guidelines
2.0.0-ballot - ballot International flag

This page is part of the Clinical Guidelines (v2.0.0-ballot: STU2 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 1.0.0. For a full list of available versions, see the Directory of published versions

ActivityDefinition: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

Active as of 2023-12-19

Generated Narrative: ActivityDefinition

Resource ActivityDefinition "cc-cpg-activity-referral-nephrology"

Profile: CPG Computable Activity Definition

CQF Knowledge capability: shareable

CQF Knowledge capability: computable

CQF Knowledge capability: publishable

CQF knowledge representation level: structured

StructureDefinition Work Group: cds

url: http://hl7.org/fhir/uv/cpg/ActivityDefinition/cc-cpg-activity-referral-nephrology

version: 2.0.0-ballot

name: ReferralNephrology

title: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

status: active

experimental: true

date: 2023-12-19 19:53:17+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

jurisdiction: World (m49.htm#001)

relatedArtifact

type: justification

display: Refer to nephrologist for co-management of treatment plan in cases of: Unclear etiology of kidney disease Rapid progression of disease (GFR decline greater than 5 mL/minute/1.73 m²/year) Acute kidney injury or abrupt sustained fall in GFR GFR less than 30 mL/minute/1.73 m² (GFR categories G4-G5) to prepare for renal replacement therapy Consistent finding of significant albuminuria (albumin/creatinine ratio of 300 mg/g or more) Hypertension resistant to treatment with 4 or more antihypertensive agents Difficulty in decreasing the level of albuminuria despite institution of ACE inhibitor or angiotensin II receptor blocker therapy Persistent electrolyte abnormalities, including hyperkalemia or high serum phosphate Recurrent or extensive nephrolithiasis Hereditary kidney disease   Nephrologist involvement is recommended when the cause of chronic kidney disease is not clear Renal biopsy may be performed to determine the cause as well as to predict disease progression and response to therapy

citation: Chronic Kidney Disease Clinical Overview. ClinicalKey. Source

url: http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75DA0232E05352E3610A5325

document

kind: ServiceRequest

code: Referral to nephrologist (SNOMED CT#306286007 "Referral to nephrologist (procedure)")

intent: proposal

timing: Events: Now()

Participants

-Type
*practitioner